scholarly journals Hepatic insulin gene therapy prevents diabetic enteropathy in STZ-treated CD-1 mice

2015 ◽  
Vol 2 ◽  
pp. 15028 ◽  
Author(s):  
Shuo You ◽  
Mallappa Anitha ◽  
Sean MD deSouza ◽  
Dingwu Jia ◽  
Xianghua Lu ◽  
...  
2008 ◽  
Vol 86 (Supplement) ◽  
pp. 11
Author(s):  
B Ren ◽  
B OʼBrien ◽  
M Byrne ◽  
E Chʼng ◽  
M Swan ◽  
...  

2008 ◽  
Vol 16 (7) ◽  
pp. 1235-1242 ◽  
Author(s):  
Darin E Olson ◽  
Adam G Campbell ◽  
Marty H Porter ◽  
Kimberly G Freeman ◽  
Emily Kelso ◽  
...  

2007 ◽  
Vol 2 (1) ◽  
pp. 27-34 ◽  
Author(s):  
Dimitry A Chistiakov ◽  
Inna Tyurina
Keyword(s):  

Diabetologia ◽  
2007 ◽  
Vol 50 (9) ◽  
pp. 1910-1920 ◽  
Author(s):  
B. Ren ◽  
B. A. O’Brien ◽  
M. A. Swan ◽  
M. E. Koina ◽  
N. Nassif ◽  
...  
Keyword(s):  

2008 ◽  
Vol 86 (Supplement) ◽  
pp. 109-110
Author(s):  
H Sollinger ◽  
T Alam ◽  
D Held ◽  
E Forsberg
Keyword(s):  

2021 ◽  
Author(s):  
Gehad Abdallah

Abstract Background: Expression of insulin in hepatocytes by hepatic gene therapy is a promising treatment of diabetes. The conversion of immature proinsulin to mature insulin occurs only in cells that contain the enzymes responsible for the cleavage of proinsulin to insulin.Results: I engineered rat proinsulin with the sites of cleavage (Furin Cleavable Sites) using site directed mutagenesis for removal of C-peptide to form the two chains A and B for mature insulin production. This engineered proinsulin was constructed into a non-viral expressing vector and regulated by glucose transporter-2 promoter to control the amount of mature insulin expressed, and to modulate the amount of glucose found in hepatocytes. The mature, active and regulated expressed insulin was secreted according to the amount of glucose regulated by the glucose transporter-2 promoter. Concolusion: For successful hepatic insulin gene therapy, insulin production must be tightly coupled to glucose concentration. Hepatocytes are excellent target cells for insulin gene therapy since, they are similar to pancreatic beta cells, they have the ability to rapidly adapt to blood glucose concentrations as they possess glucose-sensing components, such as Glucose Transporter-2.


2021 ◽  
Vol 13 (6) ◽  
pp. 485-502
Author(s):  
Yunus E Eksi ◽  
Ahter D Sanlioglu ◽  
Bahar Akkaya ◽  
Bilge Esin Ozturk ◽  
Salih Sanlioglu

Author(s):  
Fulya Erendor ◽  
Yunus Emre Eksi ◽  
Elif Ozgecan Sahin ◽  
Mustafa Kemal Balci ◽  
Thomas S. Griffith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document